Why Liberals Should Let the Kristi Noem Dog Story Fade Away
Bill Maher Said What We're All Thinking Regarding These Pro-Hamas Clowns Blocking Traffic
We Have New Info on the Alleged Police Snipers Spotted at Ohio State...
Columbia University Law Students Issue Demands of Their Own As Mob Rule Reigns
Lessons From Other Campus Protests
'Welcome to San Francisco': Schiff Victim of Theft Prior to Attending Campaign Dinner
Have You Ever Heard Any Current Politician Use the Word 'Virtue'?
What's in a Hat? MAGA Hats and Pansies
Illegals Get Separate Line at Airports Because they Don't Have Documentation Verifying Who...
Biden Admin Announces New Ukraine Security Funding,Resulting In Negative Impacts on US Mil...
Sweden: The Myth of Nordic Socialism
Continued Microsoft Cybersecurity Issues Warrant Close Examination
The Canary in the Coal Mine
Illegal Aliens Stand to Cash-In on Congressional Proposal to Increase the Additional Child...
Iran: The Growing Nuclear Threat
Tipsheet

The CDC Director Just Gave Us an Updated Vaccine Timeline

AP Photo/Alex Brandon

We've brought you a lot of exciting vaccine news these past few weeks. And there's more of it on Tuesday. Center for Disease Control Director Robert Redfield said Americans should expect a vaccine to be rolled out very, very soon. He predicted the second week of December.

Advertisement

The next question then is, who will be receiving the first doses. He answered that too.

In an interview with Fox News anchor Dana Perino, Redfield shared that the first groups to get the vaccine will probably be "nursing home residents and then some combination of health care providers and individuals at high risk for a poor outcome."

"I do think we'll have about 40 million doses of vaccine before the end of the...year," Redfield continued. "That's enough to vaccinate 20 million people. But then it will continue through January and February and hopefully by March we'll start to see vaccine available for the general public."

Advertisement

Pfizer, who vaccine its been developing with BioNTech has produced a 95 percent efficacy rate, requested an emergency authorization from the FDA. A second vaccine candidate being produced by Moderna isn't too far behind, reporting a 94 percent effectiveness. And then a third, developed by AstraZeneca, is up to 90 percent effective.

The FDA has reportedly scheduled a meeting for Dec. 10 with its Vaccines and Related Biological Products Advisory Committee to discuss Pfizer's request.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement